Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Tetzlaff

Showing results (111-120 of 224) with videos related to

Pageof 23
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2019
Correlation of Tumor Burden in Sentinel Lymph Nodes with Tumor Burden in Nonsentinel Lymph Nodes and Survival in Cutaneous MelanomaKenjiro Namikawa, Phyu P Aung, Denái R Milton, et al.
Journal of Cutaneous Pathology|July 31, 2019
Cutaneous neoplasms composed of melanoma and carcinoma: A rare but important diagnostic pitfall and review of the literatureHaider A Mejbel, Kelly C Nelson, Dinesh Pradhan, et al.
Human Pathology|March 24, 2016
Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumorsRami N Al-Rohil, Jonathan L Curry, Carlos A Torres-Cabala, et al.
Journal of Cutaneous Pathology|January 5, 2021
Tertiary lymphoid structures with overlapping histopathologic features of cutaneous marginal zone lymphoma during neoadjuvant cemiplimab therapy are associated with antitumor responseKeith J Sweeney, Michael T Tetzlaff, Francisco Vega, et al.
Oncotarget|February 29, 2020
Identification of biomarkers of immune checkpoint blockade efficacy in recurrent or refractory solid tumor malignanciesRichard K Yang, Yun Qing, Fatima Zahra Jelloul, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 6, 2013
Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanomaMichael T Tetzlaff, Jonathan L Curry, Doina Ivan, et al.
Journal of Cutaneous Pathology|April 18, 2018
Dermatologic toxicity from novel therapy using antimicrobial peptide LL-37 in melanoma: A detailed examination of the clinicopathologic featuresTsetan Dolkar, Celestine M Trinidad, Kelly C Nelson, et al.
Journal of Cutaneous Pathology|August 18, 2016
Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel findingRami N Al-Rohil, Carlos A Torres-Cabala, Anisha Patel, et al.
The American Journal of Dermatopathology|April 21, 2020
BAP-1 Expression Status by Immunohistochemistry in Cellular Blue Nevus and Blue Nevus-like MelanomaPei-Ling Chen, Nastaran Neishaboori, Michael T Tetzlaff, et al.
Journal of Cutaneous Pathology|July 10, 2020
Langerhans cell sarcoma involving skin and showing epidermotropism: A comprehensive reviewShira Ronen, Elizabeth Keiser, Katrina M Collins, et al.
Pageof 23

Showing results (111-120 of 224) with videos related to

Sort By:
Pageof 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2019
Correlation of Tumor Burden in Sentinel Lymph Nodes with Tumor Burden in Nonsentinel Lymph Nodes and Survival in Cutaneous MelanomaKenjiro Namikawa, Phyu P Aung, Denái R Milton, et al.
Journal of Cutaneous Pathology|July 31, 2019
Cutaneous neoplasms composed of melanoma and carcinoma: A rare but important diagnostic pitfall and review of the literatureHaider A Mejbel, Kelly C Nelson, Dinesh Pradhan, et al.
Human Pathology|March 24, 2016
Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumorsRami N Al-Rohil, Jonathan L Curry, Carlos A Torres-Cabala, et al.
Journal of Cutaneous Pathology|January 5, 2021
Tertiary lymphoid structures with overlapping histopathologic features of cutaneous marginal zone lymphoma during neoadjuvant cemiplimab therapy are associated with antitumor responseKeith J Sweeney, Michael T Tetzlaff, Francisco Vega, et al.
Oncotarget|February 29, 2020
Identification of biomarkers of immune checkpoint blockade efficacy in recurrent or refractory solid tumor malignanciesRichard K Yang, Yun Qing, Fatima Zahra Jelloul, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 6, 2013
Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanomaMichael T Tetzlaff, Jonathan L Curry, Doina Ivan, et al.
Journal of Cutaneous Pathology|April 18, 2018
Dermatologic toxicity from novel therapy using antimicrobial peptide LL-37 in melanoma: A detailed examination of the clinicopathologic featuresTsetan Dolkar, Celestine M Trinidad, Kelly C Nelson, et al.
Journal of Cutaneous Pathology|August 18, 2016
Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel findingRami N Al-Rohil, Carlos A Torres-Cabala, Anisha Patel, et al.
The American Journal of Dermatopathology|April 21, 2020
BAP-1 Expression Status by Immunohistochemistry in Cellular Blue Nevus and Blue Nevus-like MelanomaPei-Ling Chen, Nastaran Neishaboori, Michael T Tetzlaff, et al.
Journal of Cutaneous Pathology|July 10, 2020
Langerhans cell sarcoma involving skin and showing epidermotropism: A comprehensive reviewShira Ronen, Elizabeth Keiser, Katrina M Collins, et al.
Pageof 23